SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001559053-22-000026
Filing Date
2022-05-20
Accepted
2022-05-20 16:27:17
Documents
13
Period of Report
2022-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prta-20220517.htm   iXBRL 8-K 79081
2 EX-10.1 exhibit101prta-thirdamendm.htm EX-10.1 5942
  Complete submission text file 0001559053-22-000026.txt   234978

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20220517.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20220517_lab.xml EX-101.LAB 25750
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20220517_pre.xml EX-101.PRE 13636
7 EXTRACTED XBRL INSTANCE DOCUMENT prta-20220517_htm.xml XML 12021
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 22947972
SIC: 2834 Pharmaceutical Preparations